Strategic Pharma and Biotech Consultants with Diverse, Real-World Experience



Archbow is a strategic consulting practice for the pharma & biotech industry.


Our company was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse, real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. 


Archbow approaches every project as a unique partnership, looking beyond the traditional suite of services to deliver enduring solutions at every stage of your product’s lifecycle.


We know what it takes to propel brands to success.



map of Global pharmaceutical distribution network
Distribution Support
satepharmaceutical market intelligence radar
Market Intelligence
International Solutions
hand touching global pharmaceutical strategy
barriers to patient access
Patient Support
pharmaceutcal patient files
Payer Strategy
gant chart for pharmaceutical project management
Project Management


The work you’ve done with distributors, our HUB services vendor, and SPs has already helped us with negotiations with our potential partners (and helped me speak intelligently to the unique challenges this product brings to any launch.)  I appreciate all of your help and Archbow will be at the top of my list to call, whenever or wherever I wind up next.

— Chief Commercial Officer at a Biotech Company



November 5, 2019

In a Q&A, Rob Besse shares his thoughts on making the leap from his family’s business to consulting, what manufacturers need to know before commercialization planning, and industry trends worth watching.

October 28, 2019

When manufacturers are planning the launch of a Buy-and-Bill product, there are certain steps that are imperative to include in the launch strategy and development of support services.

October 21, 2019

Determining if your HUB should be insourced, outsourced, or a hybrid of those two options is a big decision. And finding the right answer can determine the future success of your patient access program.

September 19, 2019

Before establishing an Expanded Access Program, it’s vital for manufacturers to align internally around several crucial program decisions. These five are key.

August 26, 2019

With no roadmap for Cell and Gene Therapy, it can be overwhelming to try to stay on top of all the moving parts. This overview of 4 key CGT topics will keep you up to date.

August 12, 2019

In addition to saving time and money, investing in project management can provide competitive advantage. If your organization can deliver strategic projects quicker and more efficiently, and fewer projects fail, it positively impacts the bottom line. Includes 5 ways to...

July 30, 2019

Key takeaways from 2019 World Congress Integrate meeting. Six essentials for improving support and access from manufacturers to patients, providers, and networks. IDNs, SP contracts, 501c3 compliance, VBCs, and more.

July 23, 2019

Archbow's experience with program migrations has taught us what to anticipate, how to formulate realistic expectations, and where to find the right fit for teams needing a change. Q&A with Anna Beth Lindenmeyer

July 8, 2019

The entrance of cell and gene therapies into the market is impacting every corner of the industry. Likewise, the demand for high-quality CGT consulting services continues to grow with each passing day.

June 19, 2019

It’s crucial to appreciate the complexities of global pricing and contracting so that you can prepare the smartest approach. Understanding these four essentials is key.

Please reload



Let us know about your business, your goals, your challenges. We're experts at mapping out your path to success. Fill in the form below, email us, or give us a call. We'd love to hear from you.

U.S. office

4700 Millenia Blvd.
Suite 175
Orlando, FL 32839

(321) 355-2686

archbow map
Europe office

Dammstrasse 19

6300 Zug


+ 41 (0)41 723 23 70

© 2019 by Archbow Consulting LLC | 355-2686

Privacy Policy